CY1105106T1 - Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων - Google Patents

Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων

Info

Publication number
CY1105106T1
CY1105106T1 CY20061101027T CY061101027T CY1105106T1 CY 1105106 T1 CY1105106 T1 CY 1105106T1 CY 20061101027 T CY20061101027 T CY 20061101027T CY 061101027 T CY061101027 T CY 061101027T CY 1105106 T1 CY1105106 T1 CY 1105106T1
Authority
CY
Cyprus
Prior art keywords
aspirin
arterosclerous
thrombotic
diseases
combination
Prior art date
Application number
CY20061101027T
Other languages
English (en)
Inventor
Tony Verbeuren
Gilbert Lavielle
Bernard Cimetiere
Marie-Odile Vallez
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of CY1105106T1 publication Critical patent/CY1105106T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε νέο συνδυασμό ενός αντιθρομβωτικού και ασπιρίνης και στις φαρμακευτικές συνθέσεις που τα περιέχουν
CY20061101027T 2002-04-05 2006-07-24 Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων CY1105106T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
CY1105106T1 true CY1105106T1 (el) 2009-11-04

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101027T CY1105106T1 (el) 2002-04-05 2006-07-24 Συνδυασμος ενος αντιθρομβωτικου και ασπιρινης και η χρηση τους για την θεραπεια θρομβωτικων και αρτηριοσκληρωτικων ασθενειων

Country Status (27)

Country Link
US (1) US7618955B2 (el)
EP (1) EP1496884B1 (el)
JP (1) JP4065853B2 (el)
KR (1) KR100645143B1 (el)
CN (1) CN1297265C (el)
AR (1) AR039253A1 (el)
AT (1) ATE329591T1 (el)
AU (1) AU2003246774B2 (el)
BR (1) BR0309019A (el)
CA (1) CA2480697A1 (el)
CY (1) CY1105106T1 (el)
DE (1) DE60306133T2 (el)
DK (1) DK1496884T3 (el)
EA (1) EA006978B1 (el)
ES (1) ES2264533T3 (el)
FR (1) FR2838057B1 (el)
GE (1) GEP20074101B (el)
HK (1) HK1076034A1 (el)
MA (1) MA27114A1 (el)
MX (1) MXPA04009760A (el)
NO (1) NO20044700L (el)
NZ (1) NZ535430A (el)
PL (1) PL371620A1 (el)
PT (1) PT1496884E (el)
UA (1) UA79457C2 (el)
WO (1) WO2003084525A1 (el)
ZA (1) ZA200407593B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008001063A (es) * 2005-07-22 2008-03-19 Procter & Gamble Composiciones para reducir la incidencia de arritmia inducida por farmacos.
WO2008127682A2 (en) 2007-04-13 2008-10-23 Millennium Pharmaceuticals, Inc. Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
JP4065853B2 (ja) 2008-03-26
ZA200407593B (en) 2006-07-26
PT1496884E (pt) 2006-09-29
ES2264533T3 (es) 2007-01-01
NO20044700L (no) 2004-10-29
AR039253A1 (es) 2005-02-16
BR0309019A (pt) 2005-02-01
AU2003246774A1 (en) 2003-10-20
UA79457C2 (en) 2007-06-25
FR2838057A1 (fr) 2003-10-10
DE60306133D1 (de) 2006-07-27
US20050143354A1 (en) 2005-06-30
US7618955B2 (en) 2009-11-17
MA27114A1 (fr) 2004-12-20
CA2480697A1 (fr) 2003-10-16
DE60306133T2 (de) 2007-01-04
ATE329591T1 (de) 2006-07-15
DK1496884T3 (da) 2006-10-02
EP1496884B1 (fr) 2006-06-14
EA200401293A1 (ru) 2005-02-24
WO2003084525A1 (fr) 2003-10-16
JP2005528376A (ja) 2005-09-22
KR100645143B1 (ko) 2006-11-10
EA006978B1 (ru) 2006-06-30
CN1646111A (zh) 2005-07-27
FR2838057B1 (fr) 2005-07-08
KR20040098053A (ko) 2004-11-18
NZ535430A (en) 2006-09-29
AU2003246774B2 (en) 2007-02-15
EP1496884A1 (fr) 2005-01-19
HK1076034A1 (en) 2006-01-06
GEP20074101B (en) 2007-05-10
PL371620A1 (en) 2005-06-27
CN1297265C (zh) 2007-01-31
MXPA04009760A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
CY1110271T1 (el) Υδατικες παρατεταμενης-απελευθερωσης φαρμακοτεχνικες μορφες πρωτεϊνων
CY1113105T1 (el) Παραγωγα ξανθινης, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
CY1116992T1 (el) Μεθοδος θεραπειας της σκληρυνσης κατα πλακας αναστελλοντας τη δραση της il-17
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
BR9914044A (pt) ésteres tetrahidropirido
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
CY1108578T1 (el) Φαρμακευτικες συνθεσεις (κιτ) περιλαμβανοντας ενωσεις διϋδροπυριδινονης και εναν ανοσορυθμιστικο (ή εναν αντιφλεγμονωδη) παραγοντα και οι χρησεις αυτων
CY1114616T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
SE0301700D0 (sv) Novel compounds
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
CY1109045T1 (el) Ρετινοειδη για τη θεραπεια του εμφυσηματος
ME00548B (me) Korišćenje inhibitora il-18 za liječenje i/ili prevenciju perifernih vaskularnih bolesti
ECSP045441A (es) Nueva sal de perindopril y composiciones farmacéuticas que lo contienen
CY1109013T1 (el) Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
ECSP055844A (es) Nuevos compuestos triciclicos
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
PT1000033E (pt) Derivados heterociclicos que inibem o factor xa
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
CY1110600T1 (el) Αναλογα της βιταμινης d